Can-Fite BioPharma Ltd.CANFNYSE
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | -42.95% |
| Q4 2024 | 0.00% |
| Q3 2024 | 57.84% |
| Q2 2024 | 0.00% |
| Q1 2024 | -67.65% |
| Q4 2023 | -1.55% |
| Q3 2023 | -23.79% |
| Q2 2023 | -22.18% |
| Q1 2023 | 31.44% |
| Q4 2022 | -39.81% |
| Q3 2022 | -24.89% |
| Q2 2022 | -17.74% |
| Q1 2022 | -58.19% |
| Q4 2021 | 106.86% |
| Q3 2021 | 122.37% |
| Q2 2021 | -47.60% |
| Q1 2021 | 11.61% |
| Q4 2020 | -36.80% |
| Q3 2020 | -30.16% |
| Q2 2020 | 1.28% |
| Q1 2020 | 333.76% |
| Q4 2019 | -91.24% |
| Q3 2019 | -33.47% |
| Q2 2019 | 63.55% |
| Q1 2019 | -5.08% |
| Q4 2018 | -51.97% |
| Q3 2018 | -5.21% |
| Q2 2018 | -24.03% |
| Q1 2018 | 125.56% |
| Q4 2017 | -10.49% |
| Q3 2017 | 0.71% |
| Q2 2017 | -43.66% |
| Q1 2017 | 17.12% |
| Q4 2016 | -27.24% |
| Q3 2016 | -19.50% |
| Q2 2016 | -19.13% |
| Q1 2016 | -10.31% |
| Q4 2015 | 14.97% |
| Q3 2015 | 31.81% |